Veeva and Zifo Join Forces to Revolutionize Quality Control Processes in Biopharma

Veeva and Zifo Collaborate for Quality Control Modernization

In a notable partnership announced on January 23, 2025, Veeva Systems (NYSE: VEEV) and Zifo have joined forces to transform the quality control (QC) landscape for biopharmaceuticals. This collaboration targets the modernization of QC operations, optimizing efficiency and reducing costs in the process.

Enhancing Quality Control

The core of this partnership lies in the integration of Veeva LIMS (Laboratory Information Management System) with Zifo's data management platform, qcKen. This integration enables companies to seamlessly import data from various sources or documents into Veeva LIMS, significantly easing the master data configuration during implementation. As a result, organizations can transition away from outdated QC systems more efficiently.

Kannan Jagamoorthy, General Manager and Head of Zifo North America, expressed enthusiasm for this collaboration, noting, "We are thrilled to partner with Veeva to deliver powerful solutions to the life sciences industry. This collaboration will aid clients in accelerating Veeva LIMS adoption, streamlining operations."

Faster Implementation and ROI

Veeva is committed to providing a holistic approach to quality assurance (QA) and QC to support quality processes with greater accuracy. By utilizing qcKen, organizations can expedite the creation of test data and specifications, leading to faster site deployments and quicker returns on investment for Veeva LIMS customers.

Ashley McMillan, Senior Director of Strategy at Veeva LIMS, highlighted that Veeva LIMS is designed specifically for life sciences organizations, aiming to enhance QC operations, scale effectively, and speed up batch release cycles. The partnership with Zifo is set to enable clients to implement Veeva LIMS more rapidly and derive value sooner, thereby propelling QC modernization initiatives.

A Strategic Alliance

As part of this partnership, Zifo will operate as an official Veeva Product Partner—further building on their existing relationship as a Veeva Services Partner. This alignment showcases their joint commitment to improving QC operations across various sectors.

Both companies understand the necessity of an efficient, unified cloud LIMS and how it can enhance initial setup processes while expediting batch releases.

About the Companies

Veeva Systems

Veeva Systems is a leading cloud software provider for the life sciences sector, dedicated to innovation and customer success. With over 1,000 clients, ranging from industry giants to emerging biotechs, Veeva is committed to balancing stakeholder interests as a Public Benefit Corporation.

Zifo

Zifo specializes in AI and data-centric business solutions for science-driven organizations. With deep expertise in various industries, including pharmaceuticals, biotechnology, and chemicals, Zifo is recognized as a trusted partner for driving scientific digital innovation, serving over 190 organizations worldwide.

Conclusion

The synergy between Veeva and Zifo is poised to positively impact the biopharmaceutical industry by modernizing quality control processes. This partnership not only alleviates the burden of setting up data but also caters to the growing demand for efficient and rapid deployment of laboratory information management systems. As these technologies evolve, biopharmaceutical companies can be more agile and responsive, ultimately benefiting patient outcomes.